Human Metabolome Technologies, Inc. (TYO:6090)

Revenue by Segment

Financials in millions JPY. Fiscal year is July - June.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019	FY 2018
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Mar 31, 2019	Mar 31, 2018
Metabolome Analysis Contract Services	1.42B	-	-	-	-
Advanced Research and Development Support Project	-	1.14B	1.19B	1.25B	1.22B
Health Care Solution Business	-	312.00M	158.82M	47.49M	2.86M
Total	1.42B	1.46B	1.35B	1.30B	1.22B

Revenue by Geography

Financials in millions JPY. Fiscal year is July - June.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019	FY 2018
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Mar 31, 2019	Mar 31, 2018
Japan	1.34B	1.30B	1.05B	1.08B	1.03B
Europe and America	59.36M	119.23M	255.34M	166.56M	152.25M
Asia	19.90M	-	-	-	-
Asia-Pacific	-	31.67M	43.06M	52.41M	39.39M
Total	1.42B	1.46B	1.35B	1.30B	1.22B

Data Source: S&P Global Market Intelligence Last updated: Sep 17, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error